Book Description

During the last year or two, the scientific and medical interest in CoQ has remarkably increased to the extent that the increase might be said to be "explosive". CoQ 10 seems to be the first therapy that significantly improves the survival rate of patients as compared to those treated with conventional therapy. The book furthermore points out that cardiology should no longer be the first priority for clinical research in CoQ 10 , but immunology, although many aspects of CoQ 10 in cardiology remain for continuing research. Many interesting presentations and heated discussions on recent key issues are reflected in this volume.